Expression of vascular endothelial growth factor is a clinically useful predictor for aggressive basal cell carcinoma
ObjectivesBasal cell carcinoma (BCC) tumors are locally invasive but rarely metastatic. However, aggressive metastatic variants are being increasingly reported in elderly people. Here we investigated the clinical utility of vascular endothelial growth factor (VEGF) as a predictive biomarker for aggr...
Main Authors: | Jong Soon Choi, Dong Chan Lee, Hee Kyung Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Kosin University College of Medicine
2018-06-01
|
Series: | Kosin Medical Journal |
Subjects: | |
Online Access: | http://www.kosinmedj.org/upload/pdf/ksmc033-01-08.pdf |
Similar Items
-
Aggressive basal cell carcinoma: dermatoscopy vascular features as clues to the diagnosis
by: John Pyne, et al.
Published: (2012-07-01) -
Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality
by: Youssef AA, et al.
Published: (2018-11-01) -
Evaluation of Immunohistochemical Findings and Clinical Features associated with Local Aggressiveness in Basal Cell Carcinoma
by: Simin Shamsi meymandi, et al.
Published: (2019-08-01) -
Metastatic basal cell carcinoma
by: Isha Shah, et al.
Published: (2021-01-01) -
p16 gene expression in basal cell carcinoma.
by: Eshkoor, Sima Atoallahi, et al.
Published: (2008)